Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2025-10-14 Regulatory Filings
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2025-10-14 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice of a postal ballot issued by ZIM Laboratories Limited, dated October 13, 2025. It includes information about the dispatch of the postal ballot notice, the voting period, the appointment of a scrutinizer, and the special resolutions to be voted on, specifically the re-appointment of whole-time directors with detailed remuneration terms. The document references compliance with the Companies Act, 2013, SEBI Listing Regulations, and MCA Circulars. It is not a report of voting results but the notice initiating the postal ballot process. The content is focused on governance matters, specifically the re-appointment of directors and their remuneration, which aligns with announcements related to board or management changes. However, since it is a notice for voting on such matters rather than the announcement of the results or the actual change, it fits best under the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings or resolutions. The document is lengthy (15,000 characters) and contains substantive information, not just a brief announcement or a certification, so it is not RPA or RNS. Therefore, the most appropriate classification is PSI with high confidence.
2025-10-13 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent confirming compliance for the quarter ended 30th September 2025. It is a compliance certificate related to dematerialisation of securities and listing confirmation, not a financial report or detailed filing. The document is short (3397 characters) and primarily serves as a regulatory compliance confirmation. It does not contain financial statements, management discussion, or detailed report data. Therefore, it fits best under Regulatory Filings (RNS) as a compliance certificate and confirmation letter.
2025-10-08 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window for insiders due to upcoming financial results. It references SEBI regulations on insider trading and specifies the trading window closure period around the quarterly financial results announcement date. The document does not contain any financial data, results, or detailed report content. It is a regulatory compliance announcement related to insider trading restrictions ahead of financial results disclosure. Given the short length (1728 characters) and nature of the content, this is not a financial report or earnings release but a regulatory filing informing the exchanges about trading restrictions. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-09-26 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) regarding the allotment of equity shares upon exercise of employee stock options under the company's ESOP scheme. It details the increase in paid-up share capital, number of shares allotted, exercise price, and other regulatory compliance information under SEBI regulations. There are no financial statements, earnings data, or management discussion of results. The document is an announcement of a capital change (allotment of shares) due to ESOP exercise, not a full financial report or earnings release. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is over 6,000 characters and contains detailed regulatory disclosures about the share allotment, supporting this classification with high confidence.
2025-09-19 English
Change in Management
Board/Management Information Classification · 100% confidence The document is a formal disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the re-appointment of two Whole-Time Directors of the company, including their profiles, terms, and confirmation that they are not debarred from holding office. The content focuses on changes in the company's board of directors and management positions. There is no financial data, earnings information, or report publication mentioned. The document is not a full report but an announcement of management changes. Therefore, the appropriate classification is Board/Management Information (MANG).
2025-09-19 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.